Higher Risk Myelodysplastic Syndromes
6 clinical trials · Condition
◉ Watch Higher Risk Myelodysplastic Syndromes
| Record | Firm | Date |
|---|---|---|
| A Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02) (NCT04417517) | ALX Oncology Inc. | 2020-10-02 |
Track Higher Risk Myelodysplastic Syndromes automatically
Every clearance here is in the API, with alerts when new ones post.